CNS pipeline · person

Michael Yang

Director of Ionis Pharmaceuticals since December 2023. He was President and CEO of ViaCyte until its 2022 acquisition by Vertex, and previously Chief Commercial Officer of Acadia Pharmaceuticals and President of Janssen Biotech at Johnson & Johnson. He also serves on the board of Pacira Pharmaceuticals.

  • 1 company

Current roles

Appears with

People sharing a company with Michael.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.